Public Company Limited and its subsidiaries For the Twelfth-month period ended 31st December 2019 1. Overall performance Consolidated financial results of Patum Rice Mill and Granary Public Company Limited

Management Discussion and Analysis For the 1st Quarter 2022 ended May 31, 2022 AEON Thana Sinsap (Thailand) Public Company Limited (“the Company”) has already submitted the consolidated reviewed the

Notification of the Capital Market Supervisory Board No. TorChor. 20/2551 Re: Rules on Entering into Material Transactions Deemed as Acquisition or Disposal of Assets, and the Notification of the Board of

. Relationship : No relationship 3. The general characteristic of the transaction Net Tangible Asset (Refer to Consolidated Financial Statement 28 February 2015) NTA of target company x %holding x 100 NTA of the

analysis of consolidated financial position as at 30 June 2017 ..................................................................... 3 The analysis of operating result for six months

the capital invested in the subsidiary, SSK, at the cost price where the term of the payment of share price is limited within 2.5 years. The Company, therefore, recognized the loss from the calculation

% of paid up capital, Total investment 50 Millions baht. The acquisition of BS Myco Biotech shares will result in the BS Myco Biotech being a subsidiary of the Company. The Company signed the share

According to the resolution of the meeting of the Board of Directors No. 6/2017 of Rajthanee Hospital Public Company Limited (the “Company”) held on 10 November 2017, approving the reviewed consolidated

Seamico Securities Public Company Limited (“The Company”) would like to report operating result that has been examined by our auditor for the year ended December 31, 2017 as follows: The consolidated

Director Ratio Analysis : Consolidated Financial Statements 1Q 1Q Unit : THB million 2019 2018 Returns (%) Return on Assets * 4.4% 3.1% Return on Equity * 5.6% 3.6% Working Capital Management (Days) Trade